Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$2.68 USD
+0.15 (5.93%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.73 +0.05 (1.87%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.27 | 0.00% |
Earnings Summary
For their last quarter, Cardiff Oncology (CRDF) reported earnings of -$0.26 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 4.00%. Look out for CRDF's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.27 per share, reflecting a year-over-year decrease of 22.73%.
Earnings History
Price & Consensus
Zacks News for CRDF
Take the Zacks Approach to Beat the Markets: Navios Maritime, Coinbase Global, Virtu Financial in Focus
CRDF: What are Zacks experts saying now?
Zacks Private Portfolio Services